On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Yinghong Wang

ResearcherPublications, citations & collaboration network

Yinghong Wang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Yinghong Wang have?

ScholarIQindexed works

Yinghong Wang has 607 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Yinghong Wang have?

ScholarIQcitation count

Yinghong Wang has 16,363 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Yinghong Wang?

ScholarIQh-index

Yinghong Wang has an h-index of 52 in OpenAlex.

What is the i10-index of Yinghong Wang?

ScholarIQi10-index

Yinghong Wang has an i10-index of 129 in OpenAlex.

What is the ORCID of Yinghong Wang?

ScholarIQorcid

The ORCID for Yinghong Wang is on the source record.

What is the OpenAlex record for Yinghong Wang?

ScholarIQopenalex

The OpenAlex for Yinghong Wang is on the source record.

What are the most-cited papers on Yinghong Wang?

ScholarIQmost cited works
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly Brassil, Jeffrey M. Caterino, Ian Chau, Marc S. Ernstoff, Jennifer M. Gardner, Pamela Ginex, Sigrun Hallmeyer, Jennifer Holter Chakrabarty, Natasha B. Leighl, Jennifer S. Mammen, David F. McDermott, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura Porter, Igor Puzanov, Cristina Reichner, Bianca Santomasso, Carole Seigel, Alexander I. Spira, María E. Suarez‐Almazor, Yinghong Wang, Jeffrey S. Weber, Jedd D. Wolchok, John A. Thompson
Journal of Clinical Oncology. 20183,734 CitationsOPEN ACCESS
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Brianna Hoffner, Christopher Hoimes, Mario E. Lacouture, Frederick L. Locke, Matthew A. Lunning, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen M. Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone
Journal of the National Comprehensive Cancer Network. 2019562 CitationsOPEN ACCESS
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Benjamin H. Kaffenberger, Matthew A. Lunning, Suzanne McGettigan, Jordan P. McPherson, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Nathan A. Pennell, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Ryan Weight, Alyse Johnson-Chilla, Griselda Zuccarino-Catania, Anita M. Engh
Journal of the National Comprehensive Cancer Network. 2020489 CitationsOPEN ACCESS
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Amaka Achufusi, Philippe Armand, Meghan Berkenstock, Shailender Bhatia, Lihua E. Budde, Saurin Chokshi, Marianne Davies, Amro Elshoury, Yaron Gesthalter, Aparna Hegde, Michael D. Jain, Benjamin H. Kaffenberger, Melissa G. Lechner, Tianhong Li, Alissa Marr, Suzanne McGettigan, Jordan P. McPherson, Theresa Medina, Nisha Mohindra, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Pradnya D. Patil, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Vlad G. Zaha, Megan Lyons, Mary A. Dwyer, Lisa Hang
Journal of the National Comprehensive Cancer Network. 2022425 CitationsOPEN ACCESS
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer
Caroline A. Nebhan, Alessio Cortellini, Weijie Ma, Teja Ganta, Haocan Song, Fei Ye, Rebecca Irlmeier, Neha Debnath, Anwaar Saeed, Maluki Radford, Asrar Alahmadi, Akiva Diamond, Christopher Hoimes, Nikhil H. Ramaiya, Carolyn J. Presley, Dwight H. Owen, Sarah Abou Alaiwi, Amin H. Nassar, Biagio Ricciuti, Giuseppe Lamberti, Melissa Bersanelli, Chiara Casartelli, Sebastiano Buti, Paolo Marchetti, Raffaele Giusti, Marco Filetti, Vito Vanella, Domenico Mallardo, Shravanti Macherla, Tamara A. Sussman, Andrea Botticelli, Domenico Galetta, Annamaria Catino, Pamela Pizzutilo, Carlo Genova, Maria Giovanna Dal Bello, Foteini Kalofonou, Ella Daniels, Paolo A. Ascierto, David J. Pinato, Toni K. Choueiri, Douglas B. Johnson, Thomas U. Marron, Yinghong Wang, Abdul Rafeh Naqash
JAMA Oncology. 2021155 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account